7-107689054-T-C

Variant summary

Our verdict is Likely pathogenic. The variant received 5 ACMG points: 6P and 1B. BS1_SupportingPS3_SupportingPP3PP1PP4PM3

This summary comes from the ClinGen Evidence Repository: The c.1003T>C (p.Phe335Leu) variant has been identified in over 20 probands with Hearing loss, 6 of whom had a second pathogenic or suspected pathogenic variant in trans (PM3_VeryStrong; PMIDs: 19509082, 29293505, 25394566, 20668687, 20597900, 19426954, 19204907, 18285825, 17503324, 17357124, 17309986, 15689455, 14679580, 11317356, Laboratory for Molecular Medicine internal data). The variant has been reported to segregate with disease in one affected family member (PP1; PMID:18285825). Multiple probands presented with hearing loss and enlarged vestibular aqueducts (EVA) which are highly specific to Pendred syndrome (PP4; PMIDs: 14679580, 18285825, 19509082, 25394566, Laboratory for Molecular Medicine internal data). Evidence has been published indicating that the p.Phe335Leu variant may be pathogenic when in trans with a functionally-null or severely hypomorphic variant but not as a mono-allelic variant or in the homozygous state (PMIDs: 19204907, 24051746). The c.1003T>C (p.Phe335Leu) variant was present in 0.203% (76/30612 CI 95%) of South Asian alleles in gnomAD v2.1.1, which is a high enough frequency apply BS1_Supporting. Additionally it was present in 2.1% (27/910 CI 95%) of Amish alleles in gnomAD v3.1 (BA1). The ClinGen Hearing Loss Expert Panel believes that the evidence for the pathogenicity of this variant for Pendred syndrome outweighs the high allele frequency of the variant in population databases. Therefore, neither BS1_Supporting nor BA1 will contribute to the overall classification. A functional study demonstrates that the p.Phe335Leu variant may impact protein function (PS3_Supporting; PMID:19204907). Finally, the REVEL computational prediction analysis tool produced a score of 0.828, which is above the threshold necessary to apply PP3. In summary, this variant has been classified as likely pathogenic for autosomal recessive Pendred syndrome based on the ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: PM3_VeryStrong, PS3_Supporting, PP1, PP3, PP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA253316/MONDO:0010134/005

Frequency

Genomes: 𝑓 0.00083 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 5 hom. )

Consequence

SLC26A4
NM_000441.2 missense, splice_region

Scores

4
9
5
Splicing: ADA: 0.5408
2

Clinical Significance

Likely pathogenic reviewed by expert panel P:23U:3

Conservation

PhyloP100: 6.64

Publications

38 publications found
Variant links:
Genes affected
SLC26A4 (HGNC:8818): (solute carrier family 26 member 4) Mutations in this gene are associated with Pendred syndrome, the most common form of syndromic deafness, an autosomal-recessive disease. It is highly homologous to the SLC26A3 gene; they have similar genomic structures and this gene is located 3' of the SLC26A3 gene. The encoded protein has homology to sulfate transporters. [provided by RefSeq, Jul 2008]
SLC26A4 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • Pendred syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • athyreosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • thyroid hypoplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 5 ACMG points.

PS3
For more information check the summary or visit ClinGen Evidence Repository.
PM3
For more information check the summary or visit ClinGen Evidence Repository.
PP1
For more information check the summary or visit ClinGen Evidence Repository.
PP3
For more information check the summary or visit ClinGen Evidence Repository.
PP4
For more information check the summary or visit ClinGen Evidence Repository.
BS1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000441.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC26A4
NM_000441.2
MANE Select
c.1003T>Cp.Phe335Leu
missense splice_region
Exon 9 of 21NP_000432.1O43511-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC26A4
ENST00000644269.2
MANE Select
c.1003T>Cp.Phe335Leu
missense splice_region
Exon 9 of 21ENSP00000494017.1O43511-1
SLC26A4
ENST00000888701.1
c.1003T>Cp.Phe335Leu
missense splice_region
Exon 8 of 20ENSP00000558760.1
SLC26A4
ENST00000888700.1
c.1003T>Cp.Phe335Leu
missense splice_region
Exon 9 of 20ENSP00000558759.1

Frequencies

GnomAD3 genomes
AF:
0.000828
AC:
126
AN:
152128
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.0297
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00113
Gnomad OTH
AF:
0.000958
GnomAD2 exomes
AF:
0.000860
AC:
216
AN:
251190
AF XY:
0.000935
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00109
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.00100
Gnomad OTH exome
AF:
0.000816
GnomAD4 exome
AF:
0.00136
AC:
1981
AN:
1461496
Hom.:
5
Cov.:
31
AF XY:
0.00143
AC XY:
1038
AN XY:
727058
show subpopulations
African (AFR)
AF:
0.000149
AC:
5
AN:
33452
American (AMR)
AF:
0.0000447
AC:
2
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00107
AC:
28
AN:
26122
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39686
South Asian (SAS)
AF:
0.00248
AC:
214
AN:
86256
European-Finnish (FIN)
AF:
0.000131
AC:
7
AN:
53400
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5764
European-Non Finnish (NFE)
AF:
0.00148
AC:
1641
AN:
1111732
Other (OTH)
AF:
0.00133
AC:
80
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
96
191
287
382
478
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000828
AC:
126
AN:
152246
Hom.:
1
Cov.:
32
AF XY:
0.000793
AC XY:
59
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.0000963
AC:
4
AN:
41556
American (AMR)
AF:
0.000196
AC:
3
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00208
AC:
10
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00113
AC:
77
AN:
68010
Other (OTH)
AF:
0.000948
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
8
16
25
33
41
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000993
Hom.:
1
Bravo
AF:
0.000910
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00186
AC:
16
ExAC
AF:
0.000865
AC:
105
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00131
EpiControl
AF:
0.000949

ClinVar

ClinVar submissions
Significance:Likely pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
6
1
-
Autosomal recessive nonsyndromic hearing loss 4 (7)
5
2
-
not provided (7)
7
-
-
Pendred syndrome (7)
2
-
-
Pendred syndrome;C3538946:Autosomal recessive nonsyndromic hearing loss 4 (2)
2
-
-
SLC26A4-related disorder (2)
1
-
-
Rare genetic deafness (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.95
BayesDel_addAF
Uncertain
0.054
T
BayesDel_noAF
Pathogenic
0.30
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.69
D
Eigen
Uncertain
0.44
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.75
T
M_CAP
Uncertain
0.15
D
MetaRNN
Benign
0.079
T
MetaSVM
Uncertain
0.23
D
MutationAssessor
Benign
0.85
L
PhyloP100
6.6
PrimateAI
Uncertain
0.64
T
PROVEAN
Uncertain
-3.9
D
REVEL
Pathogenic
0.86
Sift
Benign
0.73
T
Sift4G
Benign
0.74
T
Polyphen
1.0
D
Vest4
0.71
MutPred
0.88
Gain of disorder (P = 0.1119)
MVP
0.97
MPC
0.076
ClinPred
0.10
T
GERP RS
5.6
Varity_R
0.65
gMVP
0.89
Mutation Taster
=18/82
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.54
dbscSNV1_RF
Benign
0.33
SpliceAI score (max)
0.15
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111033212; hg19: chr7-107329499; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.